Home | Links | Contact Us | More About Intellectual Property | Bookmark
Search patents:
Home Gene Therapy Antisense-inhibition-of-rank-expression

 Method for measuring no synthase activity
OF THE INVENTION In the context of the present invention the following definitions apply: I...


 Method of enhancing proliferation or differentiation of hematopoietic stem cells using Wnt polypeptides
In one aspect, the present invention pertains to the discovery herein that Wnt polypeptides ("Wnts")...


 Hydrogel compositions for controlled delivery of virus vectors and methods of use thereof
The invention relates to a composition for delivery of a virus vector to an animal cell. The ...


 Particle delivery techniques
OF THE PREFERRED EMBODIMENTS The practice of the present invention will employ, unless otherwise ...


 Tissue anchor system
The invention claimed is: 1. An adjustable tissue anchor comprising: a. an anchor body having a ...


 Ribozyme mediated inactivation of the androgen receptor
The present invention describes inactivation of AR gene expression by engineering hammerhead ...


 Thyrotropin-releasing hormone analogues and their therapeutic applications
The present invention pertains to novel TRH analogues, compositions, and methods for the controlled ...


 Probiotics in primary prevention of atopic diseases
What is claimed is: 1. A method for prevention of atopic diseases selected from the group ...


 Humanin-like peptide and use thereof
The invention claimed is: 1. A polypeptide comprising an amino acid sequence as shown in SEQ ID NO: ...


 Use of N-acetyl-D-glucosamine in the manufacture of pharmaceutical useful for suppressing side-effect of radiotherapy and chemotherapy
The invention claimed is: 1. A method for treating a cancer patient who is undergoing or has ...


 Antisense inhibition of rank expression

Details
Inventors: Baker, Brenda F.; Cowsert, Lex M.;
Assignee: Isis Pharmaceuticals, Inc. (Carlsbad, CA)
Primary Examiner: Elliott; George C.
Assistant Examiner: Zara; Jane
Attorney, Agent or Firm: Law Offices of Jane Massey Licata

Antisense compounds, compositions and methods are provided for inhibiting the expression of RANK. The compositions comprise antisense compounds, particularly antisense oligonucleotides, targeted to nucleic acids encoding RANK. Methods of using these compounds for inhibition of RANK expression and for treatment of diseases associated with expression of RANK are provided.

DETAILED DESCRIPTION OF THE INVENTION The present invention employs oligomeric antisense compounds, particularly oligonucleotides, for use in modulating the function of nucleic acid molecules encoding RANK, ultimately modulating the amount of RANK produced.
This is accomplished by providing antisense compounds which specifically hybridize with one or more nucleic acids encoding RANK.
As used herein, the terms "target nucleic acid" and "nucleic acid encoding RANK" encompass DNA encoding RANK, RNA (including pre-mRNA and mRNA) transcribed from such DNA, and also cDNA derived from such RNA.
The specific hybridization of an oligomeric compound with its target nucleic acid interferes with the normal function of the nucleic acid.
This modulation of function of a target nucleic acid by compounds which specifically hybridize to it is generally referred to as "antisense".
The functions of DNA to be interfered with include replication and transcription.
The functions of RNA to be interfered with include all vital functions such as, for example, translocation of the RNA to the site of protein translation, translation of protein from the RNA, splicing of the RNA to yield one or more mRNA species, and catalytic activity which may be engaged in or facilitated by the RNA.
The overall effect of such interference with target nucleic acid function is modulation of the expression of RANK.
In the context of the present invention, "modulation" means either an increase (stimulation) or a decrease (inhibition) in the expression of a gene.
In the context of the present invention, inhibition is the preferred form of modulation of gene expression and mRNA is a preferred target.
It is preferred to target specific nucleic acids for antisense.
"Targeting" an antisense compound to a particular nucleic acid, in the context of this invention, is a multistep process.
The process usually begins with the identification of a nucleic acid sequence whose function is to be modulated.
This may be, for example, a cellular gene (or mRNA transcribed from the gene) whose expression is associated with a particular disorder or disease state, or a nucleic acid molecule from an infectious agent



Related patents
  Antisense inhibition of protein kinase C-theta expression
OF THE INVENTION The present invention employs oligomeric antisense compounds, particularly oligonucleotides, for use in modulating the function of nucleic acid ...
  Antisense oligonucleotide modulation of human mdm2 expression
OF THE INVENTION Tumors often result from genetic changes in cellular regulatory genes. Among the most important of these are the tumor suppressor genes, of which p53 ...
  Ribavirin-interferon alfa combination therapy for eradicating detectable HCV-RNA in patients having chronic hepatitis C infection
The term "alkyl" as used herein means straight and branched carbon chains of one to twenty carbons, preferably one to six carbons and more preferably one to three ...
  Antibacterial agents comprising conjugates of glycopeptides and peptidic membrane associating elements
What is claimed is: 1. An antibacterial compound of formula V-L-W-X; wherein: V is a glycopeptide moiety which inhibits peptidoglycan biosynthesis in bacteria; L is a ...
  System and method for enhancing cardiac signal sensing by cardiac pacemakers through genetic treatment
In accordance with the above, a primary purpose of Applicants' claimed invention is to provide methods and delivery systems for enhancing cardiac pacemaker signal ...
  Recombinant allergenic proteins from ragweed pollen
The present invention relates to allergenic proteins or peptides from ragweed, DNAs encoding all or a portion of such allergenic proteins or peptides; to compositions ...
  Nucleic acids encoding allergenic proteins from ragweed
The present invention relates to allergenic proteins or peptides from ragweed, DNAs encoding all or a portion of such allergenic proteins or peptides; to compositions ...
  Lactobacilli harboring aggregation gene as a vaccine delivery vehicle
OF THE INVENTION As used herein and in the claims, the term "animal" means mammals and avians, with humans being the animal of greatest interest. As used herein and in ...
  Delivery and expression of a hybrid surface protein on the surface of gram positive bacteria
What is claimed is: 1. An isolated and purified DNA molecule encoding a hybrid protein, said hybrid protein comprising a heterologous polypeptide attached to the N-...
  Lentiviral packaging constructs
OF THE INVENTION The practice of the present invention will employ, unless otherwise indicated, conventional techniques of cell biology, molecular biology, cell culture,...

0.024

Archive: All patents - Links

Copyright (c)2006 Eipa-patents.org - All rights reserved